Biodexa Pharmaceticals
Quarterly Financials
| Values in thousands | 2023-12-31 |
|---|---|
Revenue | $83 |
Gross Profit | -2,168 |
EBITDA | -2,287 |
EBIT | -2,360 |
Net Income | -3,511 |
Net Change In Cash | 83 |
Free Cash Flow | -2,967 |
Cash | 5,971 |
Basic Shares |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $381 | $699 | $578 |
Gross Profit | -5,437 | -3,686 | -4,412 | -4,076 |
EBITDA | -9,082 | -7,161 | -7,395 | -5,659 |
EBIT | -9,199 | -7,444 | -7,738 | -6,062 |
Net Income | -5,729 | -7,079 | -7,656 | -5,460 |
Net Change In Cash | 0 | 381 | 699 | 578 |
Free Cash Flow | -13,035 | -7,089 | -7,110 | -6,328 |
Cash | 1,669 | 5,971 | 2,836 | 10,057 |
Basic Shares | 61 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$15.06 |
2025-03-31 | -$36.54 |
2022-09-30 | $0 |
2022-06-30 | $0 |
